BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Mid-Cycle Review Meeting Successfully Completed, page-32

  1. 324 Posts.
    lightbulb Created with Sketch. 91
    Shifting gears away from the cap raise chat. This remains a great step forward for BOT. Combined with a strong cash position and a register with increasingly stronger hands, the time appears nigh. The next 5 months will present a buying opportunity. If any placement holders puke in the short term for the 1c, I’ll be buying some. I sense however that puking is unlikely and we grind higher.
    Last edited by same1: 06/04/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.